Tiny Locked Nucleic Acid-based compounds inhibit entire disease-associated microRNA families

Links shared publicly online about this topic.

422
total visits

Tiny Locked Nucleic Acid-based compounds inhibit entire disease-associated microRNA families

A study published online in this week's Nature Genetics demonstrates that tiny Locked Nucleic Acid (LNA)-based compounds developed by Santaris Pharma A/S can inhibit entire disease-associated microRNA families. This provides a potential new approach for treating a variety of diseases including cancer, viral infections, cardiovascular and muscle diseases.

View full resource at news-medical.net

Tags: Genetic, Pharma, Relationship, News, disease, Nature, Genetics

Most Recently Shared on March 22, 2011 at 2:29 am By:

News-Medical.Net

Genetics News: Tiny Locked Nucleic Acid-based compounds inhibit entire disease-associated microRNA families: A s... http://bit.ly/hQSNKI

1 year ago...

Retweet

Favorite

Tiny LNA-based compounds inhibit entire disease-associated microRNA families

physorg.com — “A study published online in this week's Nature Genetics demonstrates that tiny Locked Nucleic Acid (LNA)-based compounds developed by Santaris Pharma A/S can inhibit entire disease-associated microRNA families. This provides a potential new approach for treating a variety of diseases including cancer, ...” View full resource at physorg.com